Koers Cerevel Therapeutics Holdings, Inc.
Aandelen
CERE
US15678U1280
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
42,12 USD | +0,51% | -0,06% | -0,67% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 7,64 mld. 7,13 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -456 mln. -425 mln. | Nettowinst (verlies) 2025 * | -551 mln. -514 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 709 mln. 662 mln. | Nettoliquiditeiten 2025 * | 690 mln. 644 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-16,9
x | K/w-verhouding 2025 * |
-15
x | Werknemers | 334 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 42,24% |
Recentste transcriptie over Cerevel Therapeutics Holdings, Inc.
1 dag | +0,51% | ||
1 week | -0,06% | ||
Lopende maand | -0,37% | ||
1 maand | -0,67% | ||
3 maanden | +0,04% | ||
6 maanden | +83,67% | ||
Lopend jaar | -0,67% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ronald Renaud
CEO | Chief Executive Officer | 55 | 12-06-23 |
Director of Finance/CFO | 43 | 15-05-23 | |
N. Coles
CHM | Chairman | 63 | 01-12-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 63 | 01-06-19 | |
Ruth McKernan
BRD | Director/Board Member | 66 | 04-12-20 |
Deval Patrick
BRD | Director/Board Member | 67 | 20-01-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.10% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 42,12 | +0,51% | 689 430 |
24-04-24 | 41,9 | -0,21% | 629 646 |
23-04-24 | 41,99 | -0,26% | 1 390 239 |
22-04-24 | 42,1 | -0,26% | 701 473 |
19-04-24 | 42,21 | +0,17% | 813 324 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,67% | 7,61 mld. | |
-2,26% | 104 mld. | |
+1,41% | 97,42 mld. | |
+0,79% | 22,2 mld. | |
-17,84% | 21,23 mld. | |
-11,11% | 18,33 mld. | |
-42,83% | 16,35 mld. | |
-17,63% | 15,06 mld. | |
+4,55% | 13,98 mld. | |
+32,11% | 11,66 mld. |